Bo Turek, individually, and on behalf of all others similarly situated v. Revolution Global, LLC, et al.

Summary

The United States District Court for the Northern District of Illinois granted Defendants’ motion to dismiss Bo Turek’s seven-count putative class action concerning the labeling and marketing of cannabis-infused products and cannabis concentrates under Illinois law. The court held that Counts II through VII failed because Turek did not adequately plead actual damages, dismissed the UDTPA claim without prejudice based on his stipulation, and additionally found that the common-law fraud claim failed to plead reliance on an affirmative misrepresentation with particularity. The court declined to resolve the novel question of how the Illinois Cannabis Regulation and Tax Act classifies vapable cannabis products.

Holdings

1. A plaintiff does not adequately plead actual damages under an overpayment theory merely by alleging that the plaintiff would not have purchased a product if it had been properly labeled or identified as legally compliant; the complaint must allege facts connecting the alleged misrepresentation or noncompliance to a reduction in the product's actual value.
2. A common-law fraud claim must plead with particularity that the plaintiff relied on an affirmative misrepresentation, including facts showing that the plaintiff viewed or received the alleged misrepresentation before making the purchase.
3. A fraudulent-concealment claim may be based on reliance on an omission rather than an affirmative misrepresentation, and Turek sufficiently pleaded reliance by alleging that he relied on a product warning label that omitted warnings allegedly required for cannabis-infused products.
4. A plaintiff cannot base an Illinois fraud or consumer-fraud claim on a representation or mistake concerning a statutory product classification when the alleged legal classification is discoverable through ordinary diligence.
5. Under Illinois law, express- and implied-warranty claims generally require contractual privity, and generalized public advertising, product labels, and mass-market marketing materials do not establish the direct-dealing exception where the plaintiff purchased the product from an independent dealer.
6. When an unjust-enrichment claim rests on the same allegedly improper conduct as another claim, it stands or falls with that related claim; dismissal of the underlying claims therefore requires dismissal of the unjust-enrichment claim.
7. The court declined to decide whether vapable oils are cannabis-infused products or cannabis concentrates under Illinois law because the issue was novel, technical, and unnecessary to disposition.

Questions Presented

1. Whether Turek adequately pleaded actual damages under the Illinois Consumer Fraud and Deceptive Business Practices Act, common-law fraud, fraudulent concealment, express warranty, implied warranty, and unjust enrichment.
2. Whether Turek adequately pleaded reliance on an affirmative misrepresentation for his common-law fraud claim.
3. Whether Turek's alleged misclassification of vapable cannabis products constituted a mistake of law that could not support fraud-based claims.
4. Whether the absence of contractual privity barred Turek's express- and implied-warranty claims against manufacturers whose product he purchased from an independent dispensary.
5. Whether Turek's unjust-enrichment claim failed because it rested on the same conduct underlying his dismissed claims.
6. Whether the court should resolve the novel Illinois-law question of whether vapable oils are cannabis-infused products or cannabis concentrates under the Cannabis Regulation and Tax Act.

Disposition

dismissed